Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Lung Cancer Therapeutics Market to reach USD 62214.27 Million by 2028.

Global Lung Cancer Therapeutics Market Size study, by Disease Type (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), by Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), by Sales Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecasts 2022-2028

Product Code: HLSDT-38510875
Publish Date: 6-05-2022
Page: 200

Global Lung Cancer Therapeutics Market is valued at approximately USD 26444.84 Million in 2021 and is anticipated to grow with a healthy growth rate of more than 13 % over the forecast period 2022-2028. Lung cancer therapeutics comprise all the therapies to cure it. It is a fatal lung tumour characterised by uncontrolled cell proliferation in the lung tissues. The most significant risk factor for lung cancer is cigarette smoking. Lung cancer can also be caused by prolonged exposure to cigarette smoke. The diagnosis of lung cancer is verified by a biopsy performed under bronchoscopy or CT guidance. As a result, lung cancer can be treated using chemotherapy, radiation, immunotherapy, surgery, and other methods. Rising pollution due to Industrialization, increasing funding for Research & Development, and rising prevalence of Lung Cancer have driven the Lung Cancer Therapeutics Market. For Instance: As per the reports of the American Cancer Society, there will be 236,740 lung and bronchus cancer diagnoses and 130,180 deaths in the United States in 2022. About 85 percent of those cases are predicted to be NSCLC. Also, rising advancements in Research and development of a well-structured healthcare system are most likely to boost the overall growth of the Global Lung Cancer Therapeutics Market. However, high cost of Lung Cancer Therapeutics can obstruct the market’s expansion over the projection period of 2022-2028.

The key regions considered for the global Lung Cancer Therapeutics Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Rising development of a well-structured healthcare system and presence of major key players is driving the market growth in North America. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 20222028. The market is expected to grow during the projected period, due to rising prevalence of Lung Cancer.
Major market players included in this report are:
Genentech Inc.
Eli Lillly and Company
Celgene Corporation
AstraZeneca
Pfizer Inc.
Sanofi Pharma
Novartis AG
Merck Sharp and Dohme Corp.
Millennium Pharmaceuticals Inc.
Astellas Pharma`2
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the Therapy within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Disease Type:
Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC))

By Therapy:
Targeted Therapy
Immunotherapy
Chemotherapy

By Sales Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Lung Cancer Therapeutics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Lung Cancer Therapeutics Market, by Region, 2020-2028 (USD Million)
1.2.2. Lung Cancer Therapeutics Market, by Disease Type, 2020-2028 (USD Million)
1.2.3. Lung Cancer Therapeutics Market, by Therapy, 2020-2028 (USD Million)
1.2.4. Lung Cancer Therapeutics Market, by Sales-Channel, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Lung Cancer Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Lung Cancer Therapeutics Market Dynamics
3.1. Lung Cancer Therapeutics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising pollution due to Industrialization
3.1.1.2. Increasing funding for Research & Development
3.1.1.3. Rising prevalence of Lung Cancer

3.1.2. Market Challenges
3.1.2.1. High Cost of Lung Cancer Therapeutics
3.1.3. Market Opportunities
3.1.3.1. Rising advancements in Research
3.1.3.2. Development of a well-structured Healthcare system
Chapter 4. Global Lung Cancer Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Lung Cancer Therapeutics Market, by Disease Type
6.1. Market Snapshot
6.2. Global Lung Cancer Therapeutics Market by Disease Type, Performance – Potential Analysis
6.3. Global Lung Cancer Therapeutics Market Estimates & Forecasts by Disease Type, 2018-2028 (USD Million)
6.4. Lung Cancer Therapeutics Market, Sub Segment Analysis
6.4.1. Non-Small Cell Lung Cancer (NSCLC)
6.4.2. Small Cell Lung Cancer (SCLC)

Chapter 7. Global Lung Cancer Therapeutics Market, by Therapy
7.1. Market Snapshot
7.2. Global Lung Cancer Therapeutics Market by Therapy, Performance – Potential Analysis
7.3. Global Lung Cancer Therapeutics Market Estimates & Forecasts by Therapy, 2018-2028 (USD Million)
7.4. Lung Cancer Therapeutics Market, Sub Segment Analysis
7.4.1. Targeted Therapy
7.4.2. Immunotherapy
7.4.3. Chemotherapy

Chapter 8. Global Lung Cancer Therapeutics Market, by Sales Channel
8.1. Market Snapshot
8.2. Global Lung Cancer Therapeutics Market by Sales Channel, Performance – Potential Analysis
8.3. Global Lung Cancer Therapeutics Market Estimates & Forecasts by Sales Channel 2018-2028 (USD Million)
8.4. Lung Cancer Therapeutics Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies
8.4.4. Others

Chapter 9. Global Lung Cancer Therapeutics Market, Regional Analysis

9.1. Lung Cancer Therapeutics Market, Regional Market Snapshot
9.2. North America Lung Cancer Therapeutics Market
9.2.1. U.S. Lung Cancer Therapeutics Market
9.2.1.1. Disease Type breakdown estimates & forecasts, 2018-2028
9.2.1.2. Therapy breakdown estimates & forecasts, 2018-2028
9.2.1.3. Sales Channel breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Lung Cancer Therapeutics Market
9.3. Europe Lung Cancer Therapeutics Market Snapshot
9.3.1. U.K. Lung Cancer Therapeutics Market
9.3.2. Germany Lung Cancer Therapeutics Market
9.3.3. France Lung Cancer Therapeutics Market
9.3.4. Spain Lung Cancer Therapeutics Market
9.3.5. Italy Lung Cancer Therapeutics Market
9.3.6. Rest of Europe Lung Cancer Therapeutics Market
9.4. Asia-Pacific Lung Cancer Therapeutics Market Snapshot
9.4.1. China Lung Cancer Therapeutics Market
9.4.2. India Lung Cancer Therapeutics Market
9.4.3. Japan Lung Cancer Therapeutics Market
9.4.4. Australia Lung Cancer Therapeutics Market
9.4.5. South Korea Lung Cancer Therapeutics Market
9.4.6. Rest of Asia Pacific Lung Cancer Therapeutics Market
9.5. Latin America Lung Cancer Therapeutics Market Snapshot
9.5.1. Brazil Lung Cancer Therapeutics Market
9.5.2. Mexico Lung Cancer Therapeutics Market
9.6. Rest of The World Lung Cancer Therapeutics Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Genentech, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Eli Lillly and Company
10.2.3. Celgene Corporation
10.2.4. AstraZeneca
10.2.5. Pfizer Inc.
10.2.6. Sanofi Pharma
10.2.7. Novartis AG
10.2.8. Merck Sharp and Dohme Corp.
10.2.9. Millennium Pharmaceuticals Inc.
10.2.10. Astellas Pharma`2

Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now